Life Sciences Bursting With Activity, What's Next for the Sector

TheStreet

The Life Sciences sector is excelling, with 71% of stocks in the sector currently rated a 'Buy' by Wall Street analysts. Scott Smith is the Managing Director of the Wedbush PacGrow Life Sciences Investment Banking group and spoke with TheStreet's Susannah Lee on the trends he's seeing in the sector. Smith has led numerous transactions for life science companies including IPOs and tells us the trends he's seeing investment activity for the sector. Smith also shares with us what he heard at their latest conference on which stocks investors are liking at the moment including Applied Genetic Technologies (AGTC) and Cardica (CRDC).